Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$0.42 - $0.57 $48,965 - $66,452
116,584 Added 69.69%
283,867 $136,000
Q3 2023

May 14, 2024

SELL
$0.44 - $0.98 $51,296 - $114,252
-116,584 Reduced 41.07%
167,283 $97,000
Q3 2023

Nov 14, 2023

SELL
$0.44 - $0.98 $484,890 - $1.08 Million
-1,102,023 Reduced 86.82%
167,283 $97,000
Q2 2023

May 14, 2024

BUY
$0.5 - $0.67 $267,307 - $358,192
534,615 Added 72.77%
1,269,306 $672,000
Q2 2023

Aug 14, 2023

BUY
$0.5 - $0.67 $267,307 - $358,192
534,615 Added 72.77%
1,269,306 $672,000
Q1 2023

May 14, 2024

SELL
$0.66 - $1.13 $647,301 - $1.11 Million
-980,760 Reduced 57.17%
734,691 $514,000
Q1 2023

May 11, 2023

SELL
$0.66 - $1.13 $647,301 - $1.11 Million
-980,760 Reduced 57.17%
734,691 $514,000
Q4 2022

May 14, 2024

SELL
$0.85 - $1.54 $128,223 - $232,310
-150,851 Reduced 8.08%
1,715,451 $1.58 Million
Q4 2022

Feb 13, 2023

SELL
$0.85 - $1.54 $128,223 - $232,310
-150,851 Reduced 8.08%
1,715,451 $1.58 Million
Q3 2022

May 14, 2024

BUY
$1.16 - $1.89 $1.46 Million - $2.38 Million
1,257,850 Added 206.73%
1,866,302 $2.28 Million
Q3 2022

Nov 10, 2022

BUY
$1.16 - $1.89 $1.46 Million - $2.38 Million
1,257,850 Added 206.73%
1,866,302 $2.28 Million
Q2 2022

May 14, 2024

BUY
$1.23 - $4.14 $399,239 - $1.34 Million
324,585 Added 114.34%
608,452 $803,000
Q2 2022

Aug 15, 2022

BUY
$1.23 - $4.14 $553,461 - $1.86 Million
449,969 Added 283.92%
608,452 $803,000
Q1 2022

May 16, 2022

BUY
$2.93 - $5.89 $321,242 - $645,773
109,639 Added 224.47%
158,483 $634,000
Q4 2021

Feb 14, 2022

SELL
$5.41 - $8.5 $8,742 - $13,736
-1,616 Reduced 3.2%
48,844 $264,000
Q3 2021

Nov 10, 2021

BUY
$5.95 - $8.88 $300,237 - $448,084
50,460 New
50,460 $349,000

Others Institutions Holding ACB

About AURORA CANNABIS INC


  • Ticker ACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 300,436,992
  • Market Cap $1.26B
  • Description
  • Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried ...
More about ACB
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.